SMMT
USDSummit Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$17.780
Максимум
$18.120
Минимум
$17.370
Объем
2.88M
Фундаментальные показатели компании
Рыночная капитализация
13.0B
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
4.10M
Биржа
NGM
Валюта
USD
52-недельный диапазон
Связанные новости
Summit Therapeutics to Present at Upcoming Investor Conferences
Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today announced that it will participate in and present at four upcoming investor conferences during the remainder of this year. Members of the
Overall Survival Data from HARMONi-A, Featuring Ivonescimab in Combination with Chemotherapy vs. Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC in China, to be Showcased at SITC 2025
Conducted by Akeso, HARMONi-A Represents the First Statistically Significant OS Benefit Achieved in a Phase III Study by an Ivonescimab-Containing Regimen Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the
Guggenheim Reiterates Buy on Summit Therapeutics, Maintains $40 Price Target
Guggenheim analyst Brad Canino reiterates Summit Therapeutics with a Buy and maintains $40 price target.
Summit Therapeutics Raises $500 Million in Private Placement
Fundraise Led by Leading Biopharma Institutional Investors & Insiders $500 Million in Gross & Net Proceeds Raised at Yesterday's Closing Price of $18.74 Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit,"
Barclays Maintains Underweight on Summit Therapeutics, Raises Price Target to $16
Barclays analyst Etzer Darout maintains Summit Therapeutics with a Underweight and raises the price target from $13 to $16.
HC Wainwright & Co. Maintains Buy on Summit Therapeutics, Lowers Price Target to $40
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Summit Therapeutics with a Buy and lowers the price target from $50 to $40.
Summit Therapeutics to Host ESMO Data Update & Third Quarter Earnings Call on October 20, 2025
Conference Call to be Held at 8:00am ET Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") will host an ESMO Data Update and Third Quarter Earnings Call on Monday, October 20, 2025, before the
Связанные акции
HOTH
Hoth Therapeutics Inc.
ZIONP
Zions Bancorporation N.A. Depositary Shares (Each representing 1/40th Interest in a Share of Series A Floating-Rate Non-Cumulative Perpetual Preferred Stock)
SATS
EchoStar Corporation
VHC
VirnetX Holding Corp
NE
Noble Corporation plc A Ordinary Shares
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.